Study to Assess the Safety and Efficacy of Multiple Doses of VB-201 on Biomarkers
Clinical trial NCT01159730 · COMPLETED
Trial details
- NCT number
- NCT01159730
- Sponsor
- Vascular Biogenics Ltd. operating as VBL Therapeutics
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2010-10-01
- Primary completion
- 2011-10-01
- Enrollment
- 320
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.